0 635

Cited 3 times in

Selection of a mobilization regimen for multiple myeloma based on the response to induction therapy: granulocyte-colony stimulating factor (G-CSF) alone versus high-dose cyclophosphamide plus G-CSF.

Authors
 Ji Eun Jang  ;  June-Won Cheong  ;  Soo-Jeong Kim  ;  Hyunsoo Cho  ;  Cheolwon Suh  ;  Hyewon Lee  ;  Hyeon-Seok Eom  ;  Ho-Young Yhim  ;  Won-Sik Lee  ;  Chang-Ki Min  ;  Jae Hoon Lee  ;  Joon Seong Park  ;  Jin Seok Kim 
Citation
 LEUKEMIA & LYMPHOMA, Vol.57(6) : 1389-1397, 2016 
Journal Title
LEUKEMIA & LYMPHOMA
ISSN
 1042-8194 
Issue Date
2016
MeSH
Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use* ; Cyclophosphamide/administration & dosage ; Female ; Granulocyte Colony-Stimulating Factor/administration & dosage ; Granulocyte-Macrophage Colony-Stimulating Factor/administration & dosage ; Hematopoietic Stem Cell Mobilization*/methods ; Hematopoietic Stem Cell Transplantation* ; Humans ; Male ; Middle Aged ; Multiple Myeloma/diagnosis ; Multiple Myeloma/mortality ; Multiple Myeloma/therapy* ; Remission Induction ; Transplantation Conditioning*/adverse effects ; Transplantation Conditioning*/methods ; Transplantation, Autologous ; Treatment Outcome
Keywords
Cyclophosphamide ; granulocyte-colony stimulating factor ; multiple myeloma ; stem cell mobilization
Abstract
To evaluate the feasibility of selecting amobilizationregimenbasedon theresponsetoinductiontherapy, we retrospectively analyzed 179multiplemyelomapatients who underwent stem cellmobilization. In comparison with patients who achieved at least a very good partialresponse(VGPR) toinductiontherapyand receivedgranulocyte-colonystimulatingfactor(G-CSF)aloneand patients who did not achieve a VGPR and receivedcyclophosphamide(CY) + G-CSF, treatment-related toxicity was greater and neutrophil engraftment was slower in the CY than theG-CSFgroup. The rate of requisitemobilization(≥ 2.0 × 10(6)/kg) was similar in both groups. Overall and progression-free survival was not different between patients in theG-CSFgroup and patients who achieved at least VGPR and received CY + G-CSF. In conclusion,response-adaptedselectionof amobilizationregimenis appropriate.G-CSFaloneshould be the preferred treatment for patients who achieved at least a VGPR toinductiontherapy.
Full Text
http://www.tandfonline.com/doi/abs/10.3109/10428194.2015.1102240
DOI
10.3109/10428194.2015.1102240
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Soo Jeong(김수정) ORCID logo https://orcid.org/0000-0001-8859-3573
Kim, Jin Seok(김진석) ORCID logo https://orcid.org/0000-0001-8986-8436
Jang, Ji Eun(장지은) ORCID logo https://orcid.org/0000-0001-8832-1412
Cheong, June-Won(정준원) ORCID logo https://orcid.org/0000-0002-1744-0921
Cho, Hyunsoo(조현수) ORCID logo https://orcid.org/0000-0003-2651-6403
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/146877
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links